Nanostructured Lipid Carrier-Based Delivery of Pioglitazone for Treatment of Type 2 Diabetes

• Auteurs principaux: Umair Ilyas (Auteur), Muhammad Asif (Auteur), Minglian Wang (Auteur), Reem Altaf (Auteur), Hajra Zafar (Auteur), Mirza Muhammad Faran Ashraf Baig (Auteur), Ana Cláudia Paiva-Santos (Auteur), Muhammad Abbas (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2022-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Pioglitazone (PGZ) is utilized as a therapeutic agent in the management of (type 2) diabetes to control blood glucose levels. The existing research work was intended to make and optimize PGZ-containing NLCs (nanostructured lipid carriers). The fabricated nanostructured lipid carrier preparation was...